DauriporphineCAS# 88142-60-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 88142-60-3 | SDF | Download SDF |
| PubChem ID | 137399 | Appearance | Powder |
| Formula | C20H17NO5 | M.Wt | 351.35 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | COC1=CC2=C(C=C1)C3=NC=CC4=C3C(=C(C(=C4OC)OC)OC)C2=O | ||
| Standard InChIKey | OOWSNEKQIRVGCG-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C20H17NO5/c1-23-10-5-6-11-13(9-10)17(22)15-14-12(7-8-21-16(11)14)18(24-2)20(26-4)19(15)25-3/h5-9H,1-4H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Dauriporphine shows cytotoxic activity on the target cancer cell lines. 2. Dauriporphine shows significant angiogenesis inhibitions. 3. Dauriporphine shows significant inhibitions on receptor activator of nuclear factor-κB ligand-induced differentiation of mouse bone marrow-derived macrophages into multinucleated osteoclasts. 4. Dauriporphine shows potent P-gp MDR inhibition activity with an ED50 value 0.03 microg/mL and 0.00010 microg/mL in the MES-SA/DX5 and HCT15 cells, respectively. |
| Targets | NF-kB | P-gp |
Dauriporphine Dilution Calculator
Dauriporphine Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.8462 mL | 14.2308 mL | 28.4616 mL | 56.9233 mL | 71.1541 mL |
| 5 mM | 0.5692 mL | 2.8462 mL | 5.6923 mL | 11.3847 mL | 14.2308 mL |
| 10 mM | 0.2846 mL | 1.4231 mL | 2.8462 mL | 5.6923 mL | 7.1154 mL |
| 50 mM | 0.0569 mL | 0.2846 mL | 0.5692 mL | 1.1385 mL | 1.4231 mL |
| 100 mM | 0.0285 mL | 0.1423 mL | 0.2846 mL | 0.5692 mL | 0.7115 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 6-Formyllimetin
Catalog No.:BCN3427
CAS No.:88140-31-2
- Daphniyunnine B
Catalog No.:BCN4429
CAS No.:881388-88-1
- Daphniyunnine A
Catalog No.:BCN4428
CAS No.:881388-87-0
- KU-0060648
Catalog No.:BCC1110
CAS No.:881375-00-4
- Notoginsenoside Fc
Catalog No.:BCN3853
CAS No.:88122-52-5
- JNJ-26854165 (Serdemetan)
Catalog No.:BCC2240
CAS No.:881202-45-5
- Valganciclovir
Catalog No.:BCC2026
CAS No.:88110-89-8
- Notoginsenoside Fe
Catalog No.:BCN3852
CAS No.:88105-29-7
- 30-Hydroxygambogic acid
Catalog No.:BCN3081
CAS No.:881027-36-7
- HDS 029
Catalog No.:BCC7441
CAS No.:881001-19-0
- Notoginsenoside Fa
Catalog No.:BCN3854
CAS No.:88100-04-3
- Phrixotoxin 3
Catalog No.:BCC6328
CAS No.:880886-00-0
- DuP 697
Catalog No.:BCC7064
CAS No.:88149-94-4
- Amlodipine
Catalog No.:BCC4396
CAS No.:88150-42-9
- G-1
Catalog No.:BCC6045
CAS No.:881639-98-1
- 26RFa
Catalog No.:BCC6163
CAS No.:881640-56-8
- Levistilide A
Catalog No.:BCN1197
CAS No.:88182-33-6
- 3,5,9-Trihydroxyergosta-7,22-dien-6-one
Catalog No.:BCN1318
CAS No.:88191-14-4
- MDL 28170
Catalog No.:BCC2352
CAS No.:88191-84-8
- iMDK
Catalog No.:BCC6365
CAS No.:881970-80-5
- Clofibric Acid
Catalog No.:BCC4652
CAS No.:882-09-7
- (-)-Chelidonine
Catalog No.:BCN7456
CAS No.:88200-01-5
- Notopterol
Catalog No.:BCN5386
CAS No.:88206-46-6
- H-Leu-OAll.TosOH
Catalog No.:BCC2969
CAS No.:88224-03-7
Aporphine alkaloids and their reversal activity of multidrug resistance (MDR) from the stems and rhizomes of Sinomenium acutum.[Pubmed:16964757]
Arch Pharm Res. 2006 Aug;29(8):627-32.
Chromatographic separation of the MeOH extract from the stems and rhizomes of Sinomemium acutum led to the isolation of nine alkaloids and a lignan. Their structures were determined to be Dauriporphine (1), bianfugecine (2), dauriporphinoline (3), menisporphine (4), (-)-syringaresinol (5), N-feruloyltyramine (6), acutumine (7), dauricumine (8), sinomenine (9), and magnoflorine (10) by spectroscopic means. These compounds were examined for their P-gp mediated MDR reversal activity in human cancer cells. Compound 1 showed the most potent P-gp MDR inhibition activity with an ED50 value 0.03 microg/mL and 0.00010 microg/mL in the MES-SA/DX5 and HCT15 cells, respectively.
New alkaloids and cytotoxic principles from Sinomenium acutum.[Pubmed:23059629]
Planta Med. 2012 Nov;78(17):1873-7.
Two new alkaloids, 2-demethyl-oxypalmatine (1) and 5-ethoxycarbonylsinoracutine (2), were isolated from the rhizomes of Sinomenium acutum, along with thirty-four known compounds. Cytotoxicity of the isolated compounds was examined for the MCF-7, H460, HT-29, and CEM human cancer cell lines. Dauriporphine (16), 6-O-demethylmenisporphine (17), bianfugecine (18), menisporphine (19), and 6-O-demethylDauriporphine (20) showed differential effects in their cytotoxic activity on the target cancer cell lines. Significant angiogenesis inhibitions of 16 and 19 were also observed.
Anti-osteoclastogenic effects of isoquinoline alkaloids from the rhizome extract of Sinomenium acutum.[Pubmed:26992921]
Arch Pharm Res. 2016 May;39(5):713-20.
A phytochemical investigation for the rhizome extract from Sinomenium acutum (Menispermaceae) resulted in the isolation of several active principles responsible for the anti-osteoclastogenic property of the extract, together with related isoquinoline alkaloids (1-13) including two new compounds, 1 and 2. Among isolated compounds, salutaridine (7), dauricumine (10), cheilanthifoline (12), and Dauriporphine (13) were observed to give significant inhibitions on receptor activator of nuclear factor-kappaB ligand-induced differentiation of mouse bone marrow-derived macrophages into multinucleated osteoclasts, respectively. The chemical structures of two newly isolated compounds, 1 and 2 were established as 8-demethoxycephatonine (1) and 7(R)-7,8-dihydrosinomenine (2), by spectroscopic analyses including 2D NMR experiments.
